BDBM199500 US10125145, Cpd. No. 12::US9670229, 12::n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo [3.3.1]nonan-7-yl)-1-(pyridin-2-yl)-1h- pyrrolo[2,3-b]pyridine-3-carboxamide, 2,2,2-trifluoroacetic acid salt

SMILES CN1C2COCC1CC(C2)NC(=O)c1cn(-c2ccccn2)c2ncc(F)cc12

InChI Key

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 199500   

Target5-hydroxytryptamine receptor 3A(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM199500(n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo [3.3.1]n...)
Affinity DataIC50: 0.882nMT: 2°CAssay Description:The 5-HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 3A(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM199500(n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo [3.3.1]n...)
Affinity DataIC50: 0.882nMAssay Description:The 5-HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
Go to US Patent